Mr. J. Martin Carroll, also known as Marty, has been a Director of Catalent Pharma Solutions, Inc. since July 2015. Mr. Carroll has been the Chairman of the Board at Inotek Pharmaceuticals Corporation since June 23, 2016. He has been an Independent Director at TherapeuticsMD, Inc. since March 18, 2015 and Catalent, Inc. since July 2015. He has been an Outside Director of Inotek Pharmaceuticals Corporation since April 2016. He has been an Independent Director at Mallinckrodt Public Limited Company since June 28, 2013. He serves as a Member of the Board of Trustees of Gwynedd-Mercy College. He served as the Chief Executive Officer and President of Boehringer Ingelheim GmbH and its Head, Corporate Strategy and Development from 2012 to 2013. He served as the Head of Corporate Strategy and Development for Boehringer Ingelheim's U.S. operations from 2003 to 2011. He served as the Chief Executive Officer and President of Boehringer Ingelheim in the USA from 2003 to 2011. He served as the Global Head of Strategy and Development for Boehringer Ingelheim (Germany) from 2009 to 2012. He served as the President and Chief Executive Officer of Boehringer Ingelheim Corporation from August 2002 to 2011 and Boehringer Pharmaceuticals, Inc. from 2003 to 2011. He served as the Chief Executive Officer and President of Boehringer Ingelheim Pharmaceuticals, Inc., a subsidiary of Boehringer Ingelheim Corporation since 2002. He served as the Chief Executive Officer and President of Boehringer Ingelheim, Inc.  Mr. J. Martin Carroll, also known as Marty, has been a Director of Catalent Pharma Solutions, Inc. since July 2015. Mr. Carroll has been the Chairman of the Board at Inotek Pharmaceuticals Corporation since June 23, 2016. He has been an Independent Director at TherapeuticsMD, Inc. since March 18, 2015 and Catalent, Inc. since July 2015. He has been an Outside Director of Inotek Pharmaceuticals Corporation since April 2016. He has been an Independent Director at Mallinckrodt Public Limited Company since June 28, 2013. He serves as a Member of the Board of Trustees of Gwynedd-Mercy College. He served as the Chief Executive Officer and President of Boehringer Ingelheim GmbH and its Head, Corporate Strategy and Development from 2012 to 2013. He served as the Head of Corporate Strategy and Development for Boehringer Ingelheim's U.S. operations from 2003 to 2011. He served as the Chief Executive Officer and President of Boehringer Ingelheim in the USA from 2003 to 2011. He served as the Global Head of Strategy and Development for Boehringer Ingelheim (Germany) from 2009 to 2012. He served as the President and Chief Executive Officer of Boehringer Ingelheim Corporation from August 2002 to 2011 and Boehringer Pharmaceuticals, Inc. from 2003 to 2011. He served as the Chief Executive Officer and President of Boehringer Ingelheim Pharmaceuticals, Inc., a subsidiary of Boehringer Ingelheim Corporation since 2002. He served as the Chief Executive Officer and President of Boehringer Ingelheim, Inc. 

Business Administration